CAUWENBERGH GEERT (President & CEO) received a stock award from PHIO PHARMACEUTICALS CORP.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/1/2018ACC: 0001209191-18-052657
DirectorOfficer· President & CEO
Since Aug 2018
+73.59K
Net shares
Net buyer
$86.1K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
73.59K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+73.59K
Price / share
$1.17
Trade value
$86.10K
% of position
208.7%
9/28/2018
35.26K→108.84K
Total
Net shares
+73.59K
Net value
$86.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 9/28/2018 | A · Award | +73.59K | $1.17 | $86.10K | 208.7% | 35.26K | 108.84K |
| Total | +73.59K | $86.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common stock, $0.0001 par value
IndirectShares owned450.00
Total
450.00 indirect450.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock, $0.0001 par value | 450.00 | Indirect |
| Total | 450.00 | 450.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported